| ||||||||||||||
|
|
|||||||||||||
Anesthesia & Analgesia, Vol 81, 596-602, Copyright © 1995 by International Anesthesia Research Society
GENERAL ARTICLES |
MN Avramov, MM Husain and PF White
Department of Anesthesiology, University of Texas Southwestern Medical Center, Dallas, USA.
The intravenous anesthetics which are commonly used for electroconvulsive therapy (ECT) possess dose-dependent anticonvulsant properties. Since the clinical efficacy of ECT depends on the induction of a seizure of adequate duration, it is important to determine the optimal dose of the hypnotic for use during ECT. We compared the duration of seizure activity and cognitive recovery profiles after different doses of methohexital, propofol, and etomidate administered to induce hypnosis prior to ECT. Ten outpatients with major depressive disorders receiving maintenance ECT participated in this prospective, randomized, cross-over study. Patients were premedicated with glycopyrrolate, 0.2 mg intravenously (i.v.), and labetalol, 20-30 mg i.v., and hypnosis was induced with an i.v. bolus injection of methohexital or propofol (0.75, 1.0, and 1.5 mg/kg), or etomidate (0.15, 0.2, and 0.3 mg/kg), administered over 10-15 s. Adequate muscle paralysis was achieved with succinylcholine, 1.0-1.4 mg/kg i.v. Each patient's seizure threshold was determined prior to enrollment in the study and the electrical stimulus variables were kept constant throughout the study period. After delivery of a bilateral electrical stimulus, the duration of the resulting electroencephalographic (EEG) and motor seizures were recorded. A total of 90 ECT treatments were evaluated. The durations of EEG and motor seizures were longest after etomidate and shortest after propofol. There were no significant dose- related differences in motor and EEG seizure durations (means +/- SD) after the low, intermediate, and high doses of etomidate of 44 +/- 11 and 77 +/- 19, 43 +/- 10 and 76 +/- 34, 42 +/- 16 and 78 +/- 56 s, respectively. Conversely, both methohexital and propofol, 0.75, 1.0, and 1.5 mg/kg, produced dose-dependent decreases in motor and EEG seizure durations (i.e., 37 +/- 10 and 58 +/- 12, 36 +/- 8 and 62 +/- 24, and 29 +/- 13 and 48 +/- 20 for methohexital; 34 +/- 15 and 56 +/- 29, 31 +/- 8 and 50 +/- 17, and 20 +/- 6 and 33 +/- 12 for propofol, respectively). The awakening times were similar, regardless of the hypnotic or dose administered.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
P. F. White, Q. Amos, Y. Zhang, L. Stool, M. M. Husain, L. Thornton, M. Downing, S. McClintock, and S. H. Lisanby Anesthetic considerations for magnetic seizure therapy: a novel therapy for severe depression. Anesth. Analg., July 1, 2006; 103(1): 76 - 80. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. van Zijl, P. C. Gordon, and M. F. James The Comparative Effects of Remifentanil or Magnesium Sulfate Versus Placebo on Attenuating the Hemodynamic Responses After Electroconvulsive Therapy Anesth. Analg., December 1, 2005; 101(6): 1651 - 1655. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Palmer, M. Khalil, and D. Meagher Inhalation induction with sevoflurane for electroconvulsive therapy: a case series Psychiatr. Bull., September 1, 2004; 28(9): 326 - 328. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ochiai, T. Yamada, S. Kiyama, T. Nakaoji, and J. Takeda Bispectral Index as an Indicator of Seizure Inducibility in Electroconvulsive Therapy Under Thiopental Anesthesia Anesth. Analg., April 1, 2004; 98(4): 1030 - 1035. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Recart, S. Rawal, P. F. White, S. Byerly, and L. Thornton The Effect of Remifentanil on Seizure Duration and Acute Hemodynamic Responses to Electroconvulsive Therapy Anesth. Analg., April 1, 2003; 96(4): 1047 - 1050. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. W. van den Broek, T. H.N. Groenland, A. Kusuma, P. G.H. Mulder, and J. A. Bruijn Alfentanil has no proconvulsive effect during electroconvulsive therapy Can J Anesth, February 1, 2003; 50(2): 198 - 199. [Full Text] [PDF] |
||||
![]() |
S. M. Benbow, P. Shah, and J. Crentsil Anaesthesia for electroconvulsive therapy: a role for etomidate Psychiatr. Bull., September 1, 2002; 26(9): 351 - 353. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Nishihara and S. Saito Pre-Ictal Bispectral Index Has a Positive Correlation with Seizure Duration During Electroconvulsive Therapy Anesth. Analg., May 1, 2002; 94(5): 1249 - 1252. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Ding and P. F. White Anesthesia for Electroconvulsive Therapy Anesth. Analg., May 1, 2002; 94(5): 1351 - 1364. [Full Text] [PDF] |
||||
![]() |
S. Saito, Y. Kadoi, T. Nara, M. Sudo, H. Obata, T. Morita, and F. Goto The Comparative Effects of Propofol Versus Thiopental on Middle Cerebral Artery Blood Flow Velocity During Electroconvulsive Therapy Anesth. Analg., December 1, 2000; 91(6): 1531 - 1536. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Avramov and P. F. White Etomidate: Its Pharmacologic and Physiologic Effects Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 1997; 1(2): 132 - 141. [PDF] |
||||
![]() |
Altering Anesthesia for ECT Journal Watch Psychiatry, October 1, 1995; 1995(1001): 10 - 10. [Full Text] |
||||
|